共 21 条
- [1] Palliation and remission of erythrodermic cutaneous T-cell lymphoma with a novel oral RXR-selective retinoidBLOOD, 1999, 94 (10) : 98A - 98AHeald, PWDuvic, M
- [2] Modeling, Synthesis and Biological Evaluation of Potential Retinoid X Receptor (RXR) Selective Agonists for the Treatment of Cutaneous T-Cell Lymphoma.ENDOCRINE REVIEWS, 2010, 31 (03)Furmick, J. K.Wagner, C. E.van der Vaar, A.Badshah, S. L.Marshall, P. A.Jurutka, P. W.
- [3] Phase 2 and 3 clinical trial of oral bexarotene (targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphomaARCHIVES OF DERMATOLOGY, 2001, 137 (05) : 581 - 593Duvic, MMartin, AGKim, YOlsen, EWood, GSCrowley, CAYocum, RC
- [4] Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphomaARCHIVES OF DERMATOLOGY, 2002, 138 (03) : 325 - 332Breneman, DDuvic, MKuzel, TYocum, RTruglia, JStevens, VJ
- [5] A phase II trial to evaluate the efficacy of bexarotene gel 1% in patients with parapsoriasis (to cutaneous T-CELL lymphoma)JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P137 - P137Lessin, SSteckel, SWu, H
- [6] Efficacy and Safety of AP0866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical TrialJAMA DERMATOLOGY, 2016, 152 (07) : 837 - 839Goldinger, Simone M.Bischof, Sharon GobbiFink-Puches, ReginaKlemke, Claus-DetlevDreno, BrigitteBagot, MartineDummer, Reinhard
- [7] Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety dataDRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 241 - 254Liner, KendallBrown, CelesteMcGirt, Laura Y.
- [8] Topical Chemotherapy in Cutaneous T-cell Lymphoma Positive Results of a Randomized, Controlled, Multicenter Trial Testing the Efficacy and Safety of a Novel Mechlorethamine, 0.02%, Gel in Mycosis FungoidesJAMA DERMATOLOGY, 2013, 149 (01) : 25 - 32Lessin, Stuart R.Duvic, MadeleineGuitart, JoanPandya, Amit G.Strober, Bruce E.Olsen, Elise A.Hull, Christopher M.Knobler, Elizabeth H.Rook, Alain H.Kim, Ellen J.Naylor, Mark F.Adelson, David M.Kimball, Alexa B.Wood, Gary S.Sundram, UmaWu, HongKim, Youn H.
- [9] Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides) The FLASH Phase 3 Randomized Clinical TrialJAMA DERMATOLOGY, 2022, 158 (09) : 1031 - 1039Kim, Ellen J.Mangold, Aaron R.DeSimone, Jennifer A.Wong, Henry K.Seminario-Vidal, LuciaGuitart, JoanAppel, JamesGeskin, LarisaLain, EdwardKorman, Neil J.Zeitouni, NathalieNikbakht, NedaDawes, KennethAkilov, OlegCarter, JoiShinohara, MichiKuzel, Timothy M.Piette, WarrenBhatia, NealMusiek, AmyPariser, DavidKim, Youn H.Elston, DirkBoh, ErinDuvic, MadeleineHuen, AurisPacheco, TheresaZwerner, Jeffrey P.Lee, Seung TaeGirardi, MichaelQuerfeld, ChristianeBohjanen, KimberlyOlsen, EliseWood, Gary S.Rumage, AdamDonini, OreolaHaulenbeek, AndreaSchaber, Christopher J.Straube, RichardPullion, ChristopherRook, Alain H.Poligone, Brian
- [10] Phase I Clinical Trial of O6-Benzylguanine and Topical Carmustine in the Treatment of Cutaneous T-Cell Lymphoma, Mycosis Fungoides TypeARCHIVES OF DERMATOLOGY, 2012, 148 (05) : 613 - 620Apisarnthanarax, NarinWood, Gary S.Stevens, Seth R.Carlson, SeanChan, Derek V.Liu, LiliSzabo, Sarolta K.Fu, PingfuGilliam, Anita C.Gerson, Stanton L.Remick, Scot C.Cooper, Kevin D.